Clik here to view.
Representative Conyers speech at AUTM’s 30th Anniversary Bayh-Dole event
Statement of the Honorable John Conyers, Jr. appearing at the Association of University Technology Managers 30th Anniversary of the Bayh-Dole Act Wednesday, December 1, 2010, at 10:00 a.m. Washington...
View ArticleClik here to view.
Bayh-Dole Podcast moderated by BIO with AUTM and patient advocate
Lila Feisee, Vice President for Global Intellectual Property Policy at BIO, moderated a podcast on the benefits of the Bayh-Dole Act and the need to maintain flexibility in our nation’s technology...
View ArticleClik here to view.
Fabry Patient Law Suit and Request to NIH for March-in Petition Rehearing
An article out of the Genomics Law Report discussing the recent law suit citing violations of the Bayh Dole Act. A second article from Patent Docs discusses the request for rehearing of the patients...
View ArticleClik here to view.
Foley & Lardner article on the history of the Chinese Bayh-Dole Act
China Bayh-Dole Act: A Framework Fundamental to Achieving the Economic Potential of China’s National Patent Development Strategy (2011 – 2020) By Max Lin, Foley & Lardner LLP This article is part...
View ArticleClik here to view.
Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR
Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry...
View ArticleClik here to view.
Taiwan’s Translational Research (or lack thereof)
Brady Huggett concludes in this article that, “… perhaps the biggest strike against Taiwan is a lack of translational research. There is no collective mindset that envisions products from research. And...
View ArticleClik here to view.
University Licensing Survey 2010 – AUTM
AUTM is set to release their AUTM Licensing Activity Survey Summary: FY 2010 in the fall of this year for both the U.S. and Canada. AUTM issued a AUTM 2010 survey highlights to wet the appetite....
View ArticleClik here to view.
Technology Transfer: Promoting Public-Private Collaborations for Innovation
BIO President and CEO Jim Greenwood penned an op-ed for the September issue of BioPharm International on the importance of technology transfer from academia to industry, as encouraged by the Bayh-Dole...
View Article
